Chamber and committees

I refer the member to the answer to question S5W-00633 on 13 July 2021. All answers to written Parliamentary Questions are available on the Parliament's website, the search facility for which can be found at https://www.parliament.scot/chamber-and-committees/written-questions-and-answers

The information requested is not held centrally by the Scottish Government.

The data is collected by individual NHS Health Boards and would require permissions from each to be obtained in order to conduct appropriate data linkage analysis by Public Health Scotland.

There are some circumstances where there are legitimate reasons for not prescribing pancreatic enzyme replacement therapy, such as palliative patients or due to patient’s cultural preference. However, we understand more can be done around education and monitoring to ensure our clinicians are aware of the treatment.

As part of The Scottish Governments National Cancer Recovery Plan , published in December 2020, funding has been made available to ensure equitable access to treatments across the whole of Scotland.

This includes our funded work being led by The Scottish HepatoPancreatoBiliary Network which will be directly addressing guidance on the use of pancreatic enzyme replacement therapy.

I refer the member to the answer to question S5W-00633 on‎ 13 July 2021. All answers to written Parliamentary Questions are available on the Parliament's website, the search facility for which can be found at https://www.parliament.scot/chamber-and-committees/written-questions-and-answers

The provisional HMT fiscal underspend against total budget, for each funding type, in each year since 2007 is summarised in the following table:

Table: 2007-08 to 2020-21 Provisional Outturn Variances Comparison – HM Treasury Budgets

Flood Risk Management Strategies were published by SEPA in 2015. These set out proposals for 42 flood protection schemes which were prioritised according to their cost benefit ratio and taking into account a series of additional criteria, encompassing the environmental and social impacts of flooding.

It is for local authorities to commission and take forward these Schemes. In July 2016, it was agreed by Scottish Ministers and COSLA that 80% of the flood component of the General Capital Grant would be distributed according to the SEPA prioritisation of flood protection schemes set out in the Flood Risk Management Strategies. 40 of the prioritised schemes were deemed to be eligible for grant funding.

Of the 42 prioritised schemes 9 are complete, 5 are under construction and the others are at various stages of development. 7 other schemes commissioned by local authorities prior to 2016 have also been completed since 2016.

The Transvaginal Mesh Removal (Cost Reimbursement) (Scotland) Bill was introduced on 23 June 2021. It is published on the Scottish Parliament website .

The Scottish Government does not hold any trend data for grey partridge across Scotland, due to low sample size in the Breeding Bird Survey annual monitoring scheme. The UK trend shows a 64% decline over the period 1995-2018. The more recent 10-year trend (2008-2018) is lower at a 34% decline.

There is no ring-fenced procurement budget for COP26. The Scottish Government, and relevant agencies / bodies, have procured a number of contracts among suppliers for COP26, with a total value of £416,240 through Scotland-based businesses, and £24,612 through businesses without a base in Scotland, being spent to date. Procurement is in line with relevant legislation and guidance and using existing contracts and frameworks, which include an assessment with environmental, social and/or labour laws.

I am pleased to confirm that the procurement exercise for mesh removal services outside of the NHS has now concluded and I can today announce that there have been two contracts awarded: one to Spire Healthcare in Bristol and the other to Mercy Hospital in St Louis, Missouri. The contracts are expected to start later this Summer and are subject to agreement of, and compliance with, the terms specified by NHS National Services Scotland (NHS NSS).

These additional services will complement the Complex Pelvic Mesh Removal Service already established in NHS Scotland and, alongside the option of referral to NHS England Centres, are intended to allow everyone affected by transvaginal mesh complications choice over where their treatment and care is delivered.

The procurement exercise has been undertaken in line with NHS NSS’s standard commissioning procedures, with quality of care and patient safety of paramount importance.

The Scottish Government is absolutely determined to do everything in its power to help those impacted by mesh complications and I hope that today’s announcement will be welcome news to those so badly affected.